These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1623639)

  • 1. Symbiotic relationship between a research institute and a pharmaceutical company: the Baker Institute/Glaxo Australia story.
    Angus JA
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):67-71. PubMed ID: 1623639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
    BioDrugs; 2003; 17(1):69-72. PubMed ID: 12534322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Institute for One World Health--a not-for-profit pharmaceutical company.
    Lundberg GD
    MedGenMed; 2005 Jan; 7(1):61. PubMed ID: 16369366
    [No Abstract]   [Full Text] [Related]  

  • 5. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Government initiatives in the development of a pharmaceutical industry in Australia.
    Hirst CA
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):57-61. PubMed ID: 1623637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reader's response to the webcast video editorial entitled "the institute for one world health--a not-for-profit pharmaceutical company".
    Tarzwell R
    MedGenMed; 2005 Feb; 7(1):34. PubMed ID: 16369339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current challenges for the pharmaceutical research industry].
    Chalchat B
    Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.
    Beran RG
    Med Law; 2004; 23(4):913-24. PubMed ID: 15685926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
    Winther FO; Hole OP; Nitter-Hauge S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMRAD: the first 4 years.
    Grace JP
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):63-6. PubMed ID: 1623638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scripps Florida.
    Sheppard TL
    Nat Chem Biol; 2007 Aug; 3(8):451. PubMed ID: 17637772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From academic laboratory to the market: Disclosed and undisclosed narratives of commercialization.
    Sapir A; Oliver AL
    Soc Stud Sci; 2017 Feb; 47(1):33-52. PubMed ID: 28195026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCI cooperative research and development agreements.
    Ivy SP
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):27-9. PubMed ID: 11204659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BASIC TRENDS IN SCIENTIFIC RESEARCH IN THE DEPARTMENT OF DRUG TECHNOLOGY AND GALENIC PREPARATIONS AT THE N. NARIMANOV AZERBAIJAN MEDICAL INSTITUTE].
    ALIJEV RK
    Cesk Farm; 1963 Sep; 12():348-52. PubMed ID: 14089542
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

  • 18. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty five years of the National Academy of Medical Sciences of Ukraine - progress and priorities for future of radiation medicine and biology.
    Bazyka D
    Probl Radiac Med Radiobiol; 2017 Dec; 22():10-14. PubMed ID: 29286493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?
    Chan JK; Ueda SM; Sugiyama VE; Stave CD; Shin JY; Monk BJ; Sikic BI; Osann K; Kapp DS
    J Clin Oncol; 2008 Mar; 26(9):1511-8. PubMed ID: 18285603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.